Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Link
http://www.nature.com/articles/cgt201226.pdf
Reference38 articles.
1. Vogelstein B, Kinzler KW . p53 function and dysfunction. Cell 1992; 70: 523–526.
2. Vogelstein B, Lane D, Levine AJ . Surfing the p53 network. Nature 2000; 408: 307–310.
3. Brosh R, Rotter V . When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer 2009; 9: 701–713.
4. Carson DA, Lois A . Cancer progression and p53. Lancet 1995; 346: 1009–1011.
5. Olivier M, Petitjean A, Marcel V, Petre A, Mounawar M, Plymoth A et al. Recent advances in p53 research: an interdisciplinary perspective. Cancer Gene Ther 2009; 16: 1–12.
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Revolutionizing Cancer Treatment: Harnessing the Power of Mesenchymal Stem Cells for Precise Targeted Therapy in the Tumor Microenvironment;Current Topics in Medicinal Chemistry;2024-05-23
2. Discovery of an antitumor compound from xenorhabdus stockiae HN_xs01;World Journal of Microbiology and Biotechnology;2024-02-17
3. TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress;Molecular Biology Reports;2024-01-25
4. Genetically edited T-cell membrane coated AIEgen nanoparticles effectively prevents glioblastoma recurrence;Biomaterials;2023-02
5. Ru(II)/amino acid complexes inhibit the progression of breast cancer cells through multiple mechanism-induced apoptosis;Journal of Inorganic Biochemistry;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3